One of the primary treatments for small intestinal bacterial overgrowth (SIBO) is the use of antibiotics, which aim to reduce the bacterial load in the small intestine. Below, we explore the most common antibiotic treatments for SIBO, their published efficacy rates, and potential side effects in order of efficacy.

Rifaximin

Efficacy: Approximately 70-80%

Details: Rifaximin is the most commonly prescribed antibiotic for SIBO due to its broad-spectrum activity and minimal systemic absorption. It is particularly effective against hydrogen-producing bacteria.

Research has consistently shown that Rifaximin improves symptoms in a majority of patients with SIBO, making it the first-line treatment in many cases.

Common Side Effects:

• Nausea
• Abdominal pain
• Headache
• Dizziness

Sources:

Pimentel, M. et al. (2006). “A 14-day course of rifaximin is effective in treating SIBO.” The American Journal of Gastroenterology.

Neomycin

Efficacy: Approximately 63% when used alone; 85% when combined with Rifaximin

Details: Neomycin is often used in combination with Rifaximin, especially in cases where methane-producing bacteria are involved, such as in constipation-predominant SIBO. The combination of these two antibiotics is particularly effective for patients who do not fully respond to Rifaximin alone. My own clinical experience shows a 30% improvement of outcomes in patients with elevated methane SIBO using combined Rifaximin (4 week treatment) along with neomycin (2 week treatment). I do not recommend using it alone.

Common Side Effects:

• Nausea
• Diarrhea
• Ototoxicity (hearing loss with prolonged use)
• Nephrotoxicity (kidney damage with prolonged use)

Sources:

Pimentel, M. et al. (2010). “Combination of rifaximin and neomycin is more effective than rifaximin alone in treating methane-positive SIBO.” The American Journal of Gastroenterology.

Metronidazole

Efficacy: Approximately 55-70%

Details: Metronidazole is another antibiotic option, particularly in patients who are intolerant to Rifaximin or in cases where Rifaximin is not effective. It is often combined with other antibiotics such as ciprofloxacin or neomycin to enhance its efficacy. In my own clinical experience, I use Metronidazole for 2 weeks along with rifaximin to improve SIBO outcomes in addition to treating large intestinal overgrowths that often lead to SIBO.

Common Side Effects:

• Metallic taste in the mouth
• Nausea
• Vomiting
• Diarrhea
• Potential neurotoxicity (with prolonged use)

Sources:

Lacy, B. E., & Rosemore, J. (2001). “Small intestinal bacterial overgrowth: diagnosis and treatment.” Gastroenterology & Hepatology.

Ciprofloxacin

Efficacy: Approximately 52-60%

Details: Ciprofloxacin is a broad-spectrum antibiotic used less frequently due to its lower efficacy compared to Rifaximin and potential for serious side effects. It is generally reserved for cases where other treatments have failed or are not suitable. Ciprofloxacin is a poor option for SIBO treatments since it is absorbed in the intestines too quickly to be beneficial in the mid-to-lower intestines. Additionally, its use can lead to SIBO. Other interventions are recommended.

Common Side Effects:

• Nausea
• Diarrhea
• Tendonitis and tendon rupture
• Central nervous system effects (e.g., confusion, dizziness)

Sources:

Di Stefano, M. et al. (2000). “Treatment of small intestine bacterial overgrowth with ciprofloxacin.” Alimentary Pharmacology & Therapeutics.

Amoxicillin-Clavulanate

Efficacy: Approximately 50-55%

Details: Amoxicillin-Clavulanate is sometimes used in treating SIBO, particularly in combination with other antibiotics. Its efficacy is generally lower than that of Rifaximin, but it may be beneficial for certain bacterial profiles or in patients who cannot tolerate other antibiotics. Amoxicillin-Clavulanate is commonly required by insurance companies before other options, such as Rifaximin, are authorized. However, Amoxicillin-Clavulanate is absorbed in the intestines too quickly to be beneficial in mid-to-lower intestines, making it a poor option for most SIBO cases.

Common Side Effects:

• Nausea
• Diarrhea
• Rash
• Allergic reactions

Sources:

Rao, S. S., & Nawaz, H. (2007). “Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?” The American Journal of Gastroenterology.

Tetracycline

Efficacy: Approximately 48-60%

Details: Tetracycline is another antibiotic option, though it is less commonly used due to potential side effects and slightly lower efficacy. It is often considered for patients who are intolerant to other treatments or have specific bacterial resistance patterns. Tetracycline is absorbed in the intestines too quickly to be beneficial in the mid-to-lower intestines. Therefore, it is a poor option for most SIBO cases. In some instances, it has been known to cause SIBO.

Common Side Effects:

• Photosensitivity (increased risk of sunburn)
• Gastrointestinal upset
• Discoloration of teeth (in long-term use, especially in children)
• Risk of antibiotic resistance

Sources:

Lauritano, E.C. et al. (2005). “Small intestinal bacterial overgrowth and irritable bowel syndrome.” Digestive Diseases and Sciences.

Conclusion

Antibiotics remain a cornerstone in the conventional treatment of SIBO, with Rifaximin being the best option due to its high efficacy and favorable safety profile. However, the choice of antibiotic often depends on the patient’s insurance coverage, specific symptoms, bacterial profile, and previous responses to treatment. While antibiotics can be highly effective in treating SIBO, they also carry the risk of side effects, and their use should be carefully monitored by a healthcare professional. Combination treatments incorporating both herbals and prescriptive antibiotics offer a superior approach versus single therapies.

Our SIBO experts are available to consult with Neurovanna healthcare providers for difficult cases. Become a Neurovanna provider today.

Antibiotic	Efficacy Rate	Primary Use Case	Clinical Note
Rifaximin	70–80%	Hydrogen SIBO (First-line)	Best safety profile; stay in the gut.
Neomycin	85% (Combined)	Methane SIBO (Constipation)	Use with Rifaximin; do not use alone.
Metronidazole	55–70%	Rifaximin-intolerant / Large Intestine	Good for treating underlying root causes.
Ciprofloxacin	52–60%	Last resort only	Poor option: Absorbed too quickly; can cause SIBO.
Amoxicillin	50–55%	Insurance requirement	Poor option: Often fails to reach mid-intestine.
Tetracycline	48–60%	Specific resistance	Poor option: High risk of antibiotic resistance.

Disclaimer: The content of this article is for informational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.